IRF4 mutations in chronic lymphocytic leukemia

Blood

Volumn 118, Issue 10, 2011, Pages 2827-2829

  Havelange, Violaine ^a,b   Pekarsky, Yuri ^a   Nakamura, Tatsuya ^a   Palamarchuk, Alexey ^a   Alder, Hansjuerg ^a   Rassenti, Laura ^c   Kipps, Thomas ^c   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 4; MESSENGER RNA;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; DNA BINDING; DNA POLYMORPHISM; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRISOMY 12;

EID: 80052683181     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-350579     Document Type: Article

References (15)

1. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910-1916. (Pubitemid 32064784)
2. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008;40(10):1204-1210.
3. Matsuyama T, Grossman A, Mittrücker HW, et al. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 1995;23(12):2127-2136.
4. Eisenbeis CF, Singh H, Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 1995;9(11):1377-1387.
5. Yamagata T, Nishida J, Tanaka S, et al. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol. 1996;16(4):1283-1294.
6. Mamane Y, Heylbroeck C, Génin P, et al. Interferon regulatory factors: the next generation. Gene. 1999;237(1):1-14. (Pubitemid 29406192)
7. Lu R. Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol. 2008;29(10):487-492.
8. Shaffer AL, Emre NC, Lamy L, et al. IRF4 addiction in multiple myeloma. Nature. 2008;454(7201):226-231. (Pubitemid 351969894)
9. Chapman MA, Lawrence MS, Keats JJ, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471(7339):467-472.
10. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94(6):1848-1854. (Pubitemid 29430400)
11. Chang CC, Lorek J, Sabath DE, et al. Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. Blood. 2002;100(13):4671-4675. (Pubitemid 35429714)
12. Mittrücker HW, Matsuyama T, Grossman A, et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 1997;275(5299):540-543. (Pubitemid 27051911)
13. Fanzo JC, Hu CM, Jang SY, Pernis AB. Regulation of lymphocyte apoptosis by interferon regulatory factor 4 (IRF-4). J Exp Med. 2003;197(3):303-314. (Pubitemid 36184237)
14. Shaffer AL, Emre NC, Romesser PB, Staudt LM. IRF4: Immunity. Malignancy! Therapy? Clin Cancer Res. 2009;15(9):2954-2961.
15. Saito M, Gao J, Basso K, et al. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell. 2007;12(3):280-292. (Pubitemid 47333420)